Cefmetazon


Indications and Reactions:

Role Indications Reactions
Secondary
Cellulitis 16.5%
Pancreatitis Acute 14.0%
Purulence 8.5%
Sepsis 8.0%
Gastritis 7.0%
Prostate Cancer 6.0%
Gastric Ulcer 4.5%
Pneumonia 4.5%
Drug Use For Unknown Indication 4.0%
Pyelonephritis 4.0%
Extradural Abscess 3.0%
Nutritional Support 3.0%
Spondylitis 3.0%
Benign Prostatic Hyperplasia 2.0%
Colitis Ulcerative 2.0%
Hypokalaemia 2.0%
Persecutory Delusion 2.0%
Postpartum Hypopituitarism 2.0%
Product Used For Unknown Indication 2.0%
Productive Cough 2.0%
Rhabdomyolysis 30.8%
Interstitial Lung Disease 10.3%
Toxic Epidermal Necrolysis 10.3%
Hepatic Function Abnormal 7.7%
Liver Disorder 7.7%
Diarrhoea 5.1%
Vasculitis 5.1%
Dizziness 2.6%
Dyspnoea 2.6%
Hepatitis Fulminant 2.6%
Hypoglycaemic Coma 2.6%
Insulin Autoimmune Syndrome 2.6%
Respiratory Failure 2.6%
Small Intestinal Haemorrhage 2.6%
Urinary Tract Infection 2.6%
White Blood Cell Count Decreased 2.6%
Concomitant
Prophylaxis 9.0%
Hepatectomy 8.2%
Drug Use For Unknown Indication 7.3%
Constipation 7.1%
Colitis Ulcerative 6.6%
Pneumonia 6.3%
Acquired Immunodeficiency Syndrome 5.5%
Product Used For Unknown Indication 5.0%
Cough 4.7%
Hypertension 4.6%
Cancer Pain 4.4%
Diabetes Mellitus 3.9%
Infection Prophylaxis 3.8%
Premedication 3.6%
Gastric Cancer 3.5%
Herpes Zoster 3.5%
Benign Prostatic Hyperplasia 3.3%
Bronchitis 3.3%
Epilepsy 3.2%
Hepatitis C 3.2%
Hepatic Function Abnormal 12.4%
Vomiting 12.4%
Upper Gastrointestinal Haemorrhage 8.8%
White Blood Cell Count Decreased 8.8%
Liver Disorder 6.2%
Respiratory Failure 5.3%
Pyrexia 4.4%
Rectal Cancer 4.4%
Pneumonia Bacterial 3.5%
Septic Shock 3.5%
Thrombocytopenia 3.5%
Vena Cava Thrombosis 3.5%
Viral Infection 3.5%
White Blood Cell Count Increased 3.5%
Feeling Abnormal 2.7%
Haematemesis 2.7%
Interstitial Lung Disease 2.7%
Stomatitis 2.7%
Systemic Inflammatory Response Syndrome 2.7%
Urinary Tract Infection 2.7%

Drug Data